Protection by eliprodil against excitotoxicity in cultured rat retinal ganglion cells

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 6, 1999, Pages 1170-1176

  Pang, Iok Hou ^a   Wexler, Eric M ^b   Nawy, Scott ^b   DeSantis, Louis ^a   Kapin, Michael A ^a  

^a ALCON RESEARCH LTD   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELIPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD RETINA BARRIER; CELL CULTURE; GLAUCOMA; INTRAOCULAR PRESSURE ABNORMALITY; NERVE CELL; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RABBIT; RAT; RETINA GANGLION CELL; RETINOPATHY; RISK FACTOR; SURVIVAL RATE;

ANIMALS; CELL DEATH; CELLS, CULTURED; DRUG COMBINATIONS; ELECTRIC CONDUCTIVITY; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GLUTAMIC ACID; GLYCINE; MALE; N-METHYLASPARTATE; NEUROPROTECTIVE AGENTS; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RETINAL GANGLION CELLS;

EID: 0032899330     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol. 1996;114:299-305.
2. Lucas DR, Newhouse JP. The toxic effect of sodium L-glutamate on the inner layers of the retina. Arch Ophthalmol. 1957;58:193-201.
3. Azuma N, Kawamura M, Kohsaka S. Morphological and immunohistochemical studies on degenerative changes of the retina and the optic nerve in neonatal rats injected with monosodium-L-glutamate. Acta Soc Ophthalmol Jpn. 1989;93:72-79.
4. Karlsen RL, Fonnum F. The toxic effect of sodium glutamate on rat retina: changes in putative transmitters and their corresponding enzymes. J Neurochem. 1976;27:1437-1441.
5. Olney JW. Glutamate-induced retinal degeneration in neonatal mice: electron microscopy of the acutely evolving lesion. J Neuropathol Exp Neurol. 1969;28:455-474.
6. Siliprandi R, Canella R, Carmignoto G, et al. N-methyl-D-aspartate-induced neurotoxicity in the adult rat retina. Vis Neurosci. 1992; 8:567-573.
7. Sisk DR, Kuwabara T. Histological changes in the inner retina of albino rats following intravitreal injection of monosodium L-glutamate. Graefes Arch Clin Exp Ophthalmol. 1985;223:250-258.
8. Vorwerk CK, Lipton SA, Zurakowski D, Hyman BT, Sabel BA, Dreyer EB. Chronic low-dose glutamate is toxic to retinal ganglion cells: toxicity blocked by memantine. Invest Ophthalmol Vis Sci. 1996;37:1618-1624.
9. Blanks JC, Reif-Lehrer L, Casper D. Effects of monosodium glutamate on the isolated retina of the chick embryo as a function of age: a morphological study. Exp Eye Res. 1981;32:105-124.
10. Dreyer EB, Pan Z-H, Storm S, Lipton SA. Greater sensitivity of larger retinal ganglion cells to NMDA-mediated cell death. Neuroreport. 1994;5:629-631.
11. Reif-Lehrer L, Bergenthal J, Hanninen L. Effects of monosodium glutamate on chick embryo retina in culture. Invest Ophthalmol. 1975;14:114-124.
12. Sattayasai J, Ehrlich D. Morphology of quisqualate-induced neurotoxicity in the chicken retina. Invest Ophthalmol Vis Sci. 1987; 28:106-117.
13. Sucher NJ, Aizenman E, Lipton SA. N-methyl-D-aspartate antagonists prevent kainate neurotoxicity in rat retinal ganglion cells in vitro. J Neurosci. 1991;11:966-971.
14. Tung NN, Morgan IG, Ehrlich D. A quantitative analysis of the effects of excitatory neurotoxins on retinal ganglion cells in the chick. Vis Neurosci. 1990;4:217-223.
15. Bresnick GH. Excitotoxins: a possible new mechanism for the pathogenesis of ischemic retinal damage. Arch Ophthalmol. 1989; 107:339-341.
16. Yoon YH, Marmor MF. Dextromethorphan protects retina against ischemic injury in vivo. Arch Ophthalmol. 1989;107:409-411.
17. Louzada-Junior P, Dias JJ, Santos WF, Lachat JJ, Bradford HF, Coutinho-Netto J. Glutamate release in experimental ishaemia of the retina: an approach using microdialysis. J Neurochem. 1992; 59:358-363.
18. Drejer J, Benveniste H, Diemer NH, Schousboe A. Cellular origin of ischemia-induced glutamate release from brain tissue in vivo and vitro. J Neurochem. 1985;45:145-151.
19. Scatton B, Avenet P, Benavides J, et al. Neuroprotective potential of the polyamine site-directed NMDA receptor antagonists - ifenprodil and eliprodil. In: Palfreyman MG, Reynolds IJ, Skolnick P, eds. Direct and Allosteric Control of Glutamate Receptors. Boca Raton, FL: CRC Press; 1994:139-154.
20. Scatton B, Giroux C, Thenot JP, et al. Eliprodil hydrochloride. Drugs Future. 1994;19:905-909.
21. Takahashi N, Cummins D, Caprioli J. Rat retinal ganglion cells in culture. Exp Eye Res. 1991;53:565-572.
22. 2+ channels mediate glutamatergic synaptic responses to activation of single Thy-1-immunolabeled rat retinal ganglion neurons. J Neurosci. 1995; 15:2240-2254.
23. Nakanishi S, Masu M. Molecular diversity and functions of glutamate receptors. Annu Rev Biophys Biomol Struct. 1994;23:319-348.
24. 2+ channels in rat cultured cortical neurons. Eur J Pharmacol. 1994;257:297-301.
25. Legendre P, Westbrook GL. Ifenprodil blocks N-methyl-D-aspartate receptors by a two-component system. Mol Pharmacol. 1991;40: 289-298.
26. 2+ signals. J Neurophysiol. 1994;72:2503-2516.
27. 2+ permeability in single rat retinal ganglion cells. Neuroscience. 1995;67:177-188.
28. Kitano S, Morgan J, Caprioli J. Hypoxic and excitotoxic damage to cultured rat retinal ganglion cells. Exp Eye Res. 1996;63:105-112.
29. Williams K. Ifenprodil discriminates subtypes cif the N-methyl-D-aspartate receptor selectivity and mechanisms at recombinant heteromeric receptors. Mol Pharmacol. 1993;44:851-859.
30. Carter C, Benavides J, Legendre P, et al. Ifenprodil and SL-82.0715 as cerebral anti-ischemic agents, II: evidence for N-methyl-D-aspartate receptor antagonist properties. J Pharmacol Exp Ther. 1988; 247:1222-1232.
31. Gotti B, Duverger D, Bertin J, et al. Ifenprodil and SL 82.0175 as cerebral anti-ischemic agents, I: evidence for efficacy in models of focal cerebral ischemia. J Pharmacol Exp Ther. 1988;247:1211-1221.
32. Gotti B, Benavides J, MacKenzie ET, Scatton B. The pharmacotherapy of focal cortical ishaemia in the mouse. Brain Res. 1990;522: 290-307.
33. Reyes M, Reyes A, Opitz T, Kapin MA, Stanton PK. Eliprodil, a non-competitive, NR2B-selective NMDA antagonist, protects pyramidal neurons in hippocampal slices from hypoxic/ischemic damage. Brain Res. 1998;782:212-218.
34. Kapin MA, Doshi R, Scatton B, DeSantis LM, Chandler ML. Neuroprotective effects of eliprodil in retinal excitotoxicity and ischemia. Invest Ophthalmol Vis Sci. 1999;40:1177-1182.